ClinicalTrials.Veeva

Menu

Acute Kidney Injury Biomarkers: Diagnosis and Application in Pre-operative Period of Liver Transplantation (AKIB)

U

University of Sao Paulo

Status

Unknown

Conditions

Acute Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

NCT02095431
10393 (Registry Identifier)
2013/12710-2 (Other Grant/Funding Number)

Details and patient eligibility

About

Acute kidney injury (AKI), is a common complication of patients undergoing liver transplantation. Timing and definition of AKI, usually based on serum creatinine, have been inaccurate and inconsistent.

We hypothesized that the pattern of novel biomakers elevation could be a prognostic tool to provide information on the risk of progression of AKI, the need for RRT and mortality.

Enrollment

122 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older than 18 years
  • Reception liver transplantation

Exclusion criteria

  • CKD stage 4 / 5
  • Combined organ transplants
  • Patients receiving dialysis before liver transplant operation

Trial design

122 participants in 1 patient group

with AKI and without AKI
Description:
development of AKI by sCr and by novel biomarkers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems